Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atossa Genetics

0.8491
+0.01201.43%
Pre-market: 0.85000.0009+0.11%05:40 EDT
Volume:466.88K
Turnover:396.09K
Market Cap:109.68M
PE:-4.09
High:0.8804
Open:0.8370
Low:0.8250
Close:0.8371
Loading ...

Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?

Zacks
·
20 Dec 2024

Atossa Therapeutics to present poster on Z-endoxifen at SABCS

TipRanks
·
13 Dec 2024

Atossa Therapeutics to Present Poster Describing the Discovery of Molecules Synergistic with (Z)-endoxifen for the Treatment of Breast Cancer at the 2024 San Antonio Breast Cancer Symposium

GlobeNewswire
·
12 Dec 2024

Atossa Therapeutics: 2 Mg Dose Was Associated With Higher Rates of Hot Flashes, Night Sweats and Vaginal Discharge

THOMSON REUTERS
·
11 Dec 2024

Atossa Therapeutics: No Significant Differences in Adverse Events Were Observed Between 1 Mg Dose and Placebo

THOMSON REUTERS
·
11 Dec 2024

Atossa Therapeutics Announces Full Results From Phase 2 Karisma-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density

THOMSON REUTERS
·
11 Dec 2024

Atossa Therapeutics - 1 Mg Dose Reduced Mbd by 17.3 Percentage Points, 2 Mg Dose by 23.5 VS Minimal Change in Placebo Group of 0.27

THOMSON REUTERS
·
11 Dec 2024

Atossa Therapeutics Inc - 1 Mg Dose (Z)-Endoxifen Shows Potential as Preventative Breast Cancer Therapy

THOMSON REUTERS
·
11 Dec 2024

Atossa Therapeutics' Breast Cancer Treatment Demonstrates Tumor Suppression

MT Newswires Live
·
11 Dec 2024

Atossa Therapeutics Presents Data from Study Investigating Anti-Cancer Activity of (Z)-Endoxifen-Related Compounds at AACR Special Conference in Cancer Research

GlobeNewswire
·
09 Dec 2024

Atossa Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
09 Dec 2024